Quarterly Statement Of Cash Flows

Morpho,Inc. - Filing #7287039

Concept 2023-11-01 to
2024-10-31
As at
2024-10-31
2023-11-01 to
2024-10-31
As at
2023-10-31
2022-11-01 to
2023-10-31
2022-11-01 to
2023-10-31
As at
2022-10-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
297,145,000 JPY
-47,360,000 JPY
-329,784,000 JPY
-258,238,000 JPY
Depreciation
28,377,000 JPY
30,890,000 JPY
Impairment losses
1,057,000 JPY
66,137,000 JPY
Increase (decrease) in allowance for doubtful accounts
-40,383,000 JPY
-7,796,000 JPY
Interest expenses
1,361,000 JPY
722,000 JPY
Foreign exchange losses (gains)
4,664,000 JPY
-20,665,000 JPY
Loss (gain) on sale of property, plant and equipment
-169,000 JPY
-850,000 JPY
Decrease (increase) in inventories
32,032,000 JPY
-23,439,000 JPY
Increase (decrease) in trade payables
79,174,000 JPY
-33,388,000 JPY
Other, net
22,200,000 JPY
35,696,000 JPY
Subtotal
243,492,000 JPY
-242,442,000 JPY
Interest and dividends received
1,757,000 JPY
440,000 JPY
Interest paid
-1,361,000 JPY
-722,000 JPY
Income taxes paid
-52,740,000 JPY
-46,107,000 JPY
Net cash provided by (used in) operating activities
207,178,000 JPY
-267,617,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-12,543,000 JPY
-59,704,000 JPY
Proceeds from sale of property, plant and equipment
169,000 JPY
850,000 JPY
Net cash provided by (used in) investing activities
-140,719,000 JPY
-92,497,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
146,426,000 JPY
JPY
Purchase of treasury shares
-69,000 JPY
JPY
Net cash provided by (used in) financing activities
131,834,000 JPY
-16,211,000 JPY
Effect of exchange rate change on cash and cash equivalents
25,109,000 JPY
28,824,000 JPY
Net increase (decrease) in cash and cash equivalents
223,403,000 JPY
-347,502,000 JPY
Cash and cash equivalents
2,935,878,000 JPY
2,712,474,000 JPY
3,059,977,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.